CHU de Liège

Liège, Liège 4000

3 studies enrolling now · 5 studies all time

What they study most

Bladder Cancer, Cervix Cancer, Colorectal Cancer Liver Metastases (CRLM), Endometrium Cancer, Esophagus Cancer, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Liver Cancer, Liver Metastases, Lung Cancer (NSCLC), Ovary Cancer, Primary Biliary Cholangitis

Studies at this site

• DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection. — Recruiting now
• The DRAGON 2 Trial — Recruiting now
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — Completed